Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01090388 · ClinicalTrials.gov registry record
Bladder Cancer Patient-Reported Outcomes
A clinical trial of Bladder Neoplasms, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 108
- Enrollment target
- 1
- Study location
NCT01090388: Completed study of Bladder Neoplasms, sponsored by Baylor College of Medicine.
NCT01090388 is a study of Bladder Neoplasms that has completed, run by Baylor College of Medicine. The registered enrollment target is 108 participants, below the 1,876-participant average among 3 other Bladder Neoplasms trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01090388, a study of Bladder Neoplasms, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify aspects of the bladder cancer (BlCa) survivorship experience that differ by clinical risk at diagnosis. The investigators will collect cross-sectional data from persons with BlCa to identify aspects of health-related quality of life (HRQOL) and symptom management. The study originally enrolled only nonmuscle-invasive bladder cancer survivors but has been expanded to include survivors with any stage disease. Information from this study will be used to develop a new patient education and counseling intervention.
Primary Outcome
Health-related quality of life as measured by the European Organization for Resarch and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) C30 and BLS24 (that is, BLadder cancer Superficial, meaning nonmuscle-invasive) or BLM30 (BLadder cancer muscle-invasive or metastatic). Data are assessed at one time point only. Survey participants may be assessed at any point between diagnosis and 4 years post-diagnosis. The questions in the survey typically ask about health-related quality of
Conditions Studied
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2007-07 |
| Est. Completion | 2016-11 |
What the finished NCT01090388 record still lists
NCT01090388 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,876-participant average among 3 other Bladder Neoplasms trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Bladder Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT01090388 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01090388 about?
NCT01090388 is a clinical study titled "Bladder Cancer Patient-Reported Outcomes". The purpose of this study is to identify aspects of the bladder cancer (BlCa) survivorship experience that differ by clinical risk at diagnosis. The investigators will collect cross-sectional data from persons with BlCa to identify aspects of health-related quality of life (HRQOL) and symptom manage...
What is the current status of trial NCT01090388?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2007-07. Estimated completion is 2016-11.
What conditions does trial NCT01090388 study?
This clinical trial studies the following conditions: Bladder Neoplasms.
Who is sponsoring clinical trial NCT01090388?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01090388 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia